Bleselumab
Monoclonal antibody | |
---|---|
Type | ? |
Source | Human |
Target | CD40 |
Clinical data | |
Synonyms | ASKP1240 |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C6412H9906N1690O2018S38 |
Molar mass | 144.2 g/mol |
Bleselumab (INN[1]) (ASKP1240) is a human monoclonal antibody designed for the prevention of organ transplant rejection.
This drug was developed by Kyowa Kirin Pharmaceutical Development Inc.[2]
References
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.